Papillary thyroid carcinoma in Denmark, 1996-2008: Outcome and evaluation of established prognostic scoring systems in a prospective national cohort

Thyroid

Volumn 25, Issue 1, 2015, Pages 78-84

  Londero, Stefano Christian ^a   Krogdahl, Annelise ^a   Bastholt, Lars ^a   Overgaard, Jens ^b   Pedersen, Henrik Baymler ^c   Hahn, Christoffer Holst ^d   Bentzen, Jens ^e   Schytte, Sten ^b   Christiansen, Peer ^b   Gerke, Oke ^a   Godballe, Christian ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d Mental Health Center Glostrup   (Denmark)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; COHORT ANALYSIS; DENMARK; DISTANT METASTASIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; PROSPECTIVE STUDY; RECURRENCE FREE SURVIVAL; SCORING SYSTEM; THYROID CARCINOMA; TUMOR VOLUME; DISEASE FREE SURVIVAL; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PAPILLARY CARCINOMA; PROGNOSIS; SURVIVAL RATE; THYROID TUMOR;

ADULT; CARCINOMA, PAPILLARY; COHORT STUDIES; DENMARK; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; THYROID NEOPLASMS;

EID: 84920841987     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2014.0294     Document Type: Article

References (30)

1. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167.
2. Londero SC, Krogdahl A, Bastholt L, Overgaard J, Pedersen HB, Frisch T, Bentzen J, Pedersen PU, Christiansen P, Godballe C 2013 Papillary thyroid carcinoma in Denmark 1996-2008: an investigation of changes in incidence. Cancer Epidemiol 37:e1-e6.
3. Elaraj DM, Sturgeon C 2009 Adequate surgery for papillary thyroid cancer. Surgeon 7:286-289.
4. Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL, Powell CC, van Heerden JA, Goellner JR 2002 Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879-885.
5. Byar DP, Green SB, Dor P, Williams ED, Colon J, van Gilse HA, Mayer M, Sylvester RJ, van GM 1979A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer 15:1033-1041.
6. Cady B, Rossi R 1988 An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104:947-953.
7. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS 1993 Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1057.
8. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A AJCC Cancer Staging Handbook: TNM Classification of Malignant Tumors. Seventh ed. Springer, New York.
9. Pathak KA, Leslie WD, Klonisch TC, Nason RW 2013 The changing face of thyroid cancer in a population-based cohort. Cancer Med 2:537-544.
10. Hay ID 2010 Managing patients with a preoperative diagnosis of AJCC/UICC stage I (T1N0M0) papillary thyroid carcinoma: East versus West, whose policy is best? World J Surg 34:1291-1293.
11. Londero SC 2014 Completeness and validity in a national clinical thyroid cancer database-DATHYRCA. Cancer Epidemiol 2014 Aug 14 [Epub ahead of print]; DOI: 10.1016/j.canep.2014.07.009.
12. Harrell FE Jr, Lee KL, Mark DB 1996 Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387.
13. Londero SC, Krogdahl A, Bastholt L, Overgaard J, Trolle W, Pedersen HB, Bentzen J, Schytte S, Christiansen P, Godballe C 2013 Papillary thyroid microcarcinoma in Denmark 1996-2008: a national study of epidemiology and clinical significance. Thyroid 23:1159-1164.
14. Silver CE, Owen RP, Rodrigo JP, Rinaldo A, Devaney KO, Ferlito A 2011 Aggressive variants of papillary thyroid carcinoma. Head Neck 33:1052-1059.
15. National retningslinier for udredning og behandling af thyreoideacanceri Danmark. Available at: www.dahanca .dk/get-media-file.php?mediaid=255 (accessed June 30, 2014).
16. Godballe C, Madsen AR, Pedersen HB, Sorensen CH, Pedersen U, Frisch T, Helweg-Larsen J, Barfoed L, Illum P, Monsted JE, Becker B, Nielsen T 2009 Post-thyroidectomy hemorrhage: a national study of patients treated at the Danish departments of ENT Head and Neck Surgery. Eur Arch Otorhinolaryngol 266:1945-1952.
17. Godballe C, Madsen AR, Sorensen CH, Schytte S, Trolle W, Helweg-Larsen J, Barfoed L, Kristiansen L, Sorensen VZ, Samuelsen G, Pedersen HB 2014 Risk factors for recurrent nerve palsy after thyroid surgery: a national study of patients treated at Danish departments of ENT Head and Neck Surgery. Eur Arch Otorhinolaryngol 271:2267-2276.
18. Grogan RH, Kaplan SP, Cao H, Weiss RE, Degroot LJ, Simon CA, Embia OM, Angelos P, Kaplan EL, Schechter RB 2013A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery 154:1436-1447.
19. Toniato A, Boschin I, Casara D, Mazzarotto R, Rubello D, Pelizzo M 2008 Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol 15: 1518-1522.
20. Konturek A, Barczynski M, Nowak W, Richter P 2012 Prognostic factors in differentiated thyroid cancer-A 20-year surgical outcome study. Langenbecks Arch Surg 397:809-815.
21. Pelizzo MR, Boschin IM, Toniato A, Piotto A, Pagetta C, Gross MD, Al-Nahhas A, Rubello D 2007 Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients. Clin Nucl Med 32:440-444.
22. Bellantone R, Lombardi CP, Boscherini M, Ferrante A, Raffaelli M, Rubino F, Bossola M, Crucitti F 1998 Prognostic factors in differentiated thyroid carcinoma: a multivariate analysis of 234 consecutive patients. J Surg Oncol 68:237-241.
23. Eustatia-Rutten CF, Corssmit EP, Biermasz NR, Pereira AM, Romijn JA, Smit JW 2006 Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab 91:313-319.
24. Lundgren CI, Hall P, Dickman PW, Zedenius J 2006 Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106:524-531.
25. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428.
26. Ito Y, Miyauchi A 2012 Prognostic factors of papillary and follicular carcinomas in Japan based on data of Kuma Hospital. J Thyroid Res 2012:973497.
27. Randolph G, Duh QY, Heller KS, LiVolsi VA, Mandel SJ, Steward D, Tufano RP, Tuttle RM 2012 The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension: ATA Surgical Affairs Committee's Taskforce on Thyroid Cancer Nodal Surgery. Thyroid 22:1144-1152.
28. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
29. Meixner M, Hellmich M, Dietlein M, Kobe C, Schicha H, Schmidt M 2013 Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size. Nuklearmedizin 52:71-80.
30. Lang BH, Lo CY, Chan WF, Lam KY, Wan KY 2007 Staging systems for papillary thyroid carcinoma: a review and comparison. Ann Surg 245:366-378.